Truist Financial Corp Ligand Pharmaceuticals Inc Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 2,645 shares of LGND stock, worth $324,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,645

Holding current value

$324,541

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$82.7 - $110.11 $218,741 - $291,240	2,645 New	2,645 $264,000
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $161,919 - $351,155	-1,627 Closed	0 $0
Q4 2020 Nov 19, 2021	SELL	$80.55 - $106.05 $84,174 - $110,822	-1,045 Reduced 39.11%	1,627 $162,000
Q4 2020 Feb 18, 2021	SELL	$80.55 - $106.05 $131,054 - $172,543	-1,627 Reduced 37.85%	2,672 $266,000
Q3 2020 Nov 13, 2020	SELL	$89.56 - $126.72 $139,086 - $196,796	-1,553 Reduced 26.54%	4,299 $410,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $137,311 - $248,660	2,011 Added 52.36%	5,852 $654,000
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $7,477 - $12,729	118 Added 3.17%	3,841 $279,000
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $129,996 - $152,324	1,341 Added 56.3%	3,723 $389,000
Q3 2019 Oct 31, 2019	SELL	$86.25 - $120.16 $7,417 - $10,333	-86 Reduced 3.48%	2,382 $237,000
Q2 2019 Jul 24, 2019	SELL	$107.38 - $129.34 $18,147 - $21,858	-169 Reduced 6.41%	2,468 $282,000
Q1 2019 Apr 23, 2019	BUY	$105.93 - $142.47 $53,282 - $71,662	503 Added 23.57%	2,637 $332,000
Q4 2018 Jan 22, 2019	SELL	$128.36 - $272.13 $21,949 - $46,534	-171 Reduced 7.42%	2,134 $289,000
Q3 2018 Oct 17, 2018	SELL	$211.18 - $274.49 $17,527 - $22,782	-83 Reduced 3.48%	2,305 $632,000
Q2 2018 Jul 26, 2018	SELL	$150.77 - $207.98 $31,812 - $43,883	-211 Reduced 8.12%	2,388 $494,000
Q1 2018 Apr 20, 2018	SELL	$138.63 - $182.62 $3,188 - $4,200	-23 Reduced 0.88%	2,599 $429,000
Q4 2017 Jan 29, 2018	SELL	$128.36 - $147.04 $7,444 - $8,528	-58 Reduced 2.16%	2,622 $359,000
Q3 2017 Oct 23, 2017	BUY	$120.91 - $137.94 $324,038 - $369,679	2,680	2,680 $365,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Ligand Pharmaceuticals Inc Transaction History